Clinical trial
Prospective Cohort Study of the Risk of Recurrent Atrial Fibrillation After Radiofrequency Ablation
NCT05638841 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Cohort Study of the Risk of Recurrent Atrial Fibrillation After Radiofrequency Ablation
- Lead sponsor
- Peking University Third Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- January 1, 2023
- Completion date
- December 31, 2026
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.